Profile data is unavailable for this security.
About the company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
- Revenue in ILS (TTM)62.59bn
- Net income in ILS-3.71bn
- Incorporated1944
- Employees35.00k
- LocationTeva- Pharmaceutical Industries Ltd.124 Dvora Hanevi'a St.TEL AVIV-YAFO 6944020IsraelISR
- Phone+972 39148213
- Fax+972 39234050
- Websitehttps://www.tevapharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hansoh Pharmaceutical Group Company Ltd | 6.24bn | 2.43bn | 50.89bn | 9.10k | 21.17 | 3.53 | 19.28 | 8.15 | 0.8437 | 0.8437 | 2.16 | 5.06 | 0.3804 | 1.81 | 3.89 | 1,425,881.00 | 14.82 | 11.58 | 17.87 | 13.98 | 91.01 | 90.78 | 38.97 | 29.28 | 7.81 | -- | 0.0043 | 12.75 | 7.69 | 5.52 | 26.85 | 11.49 | -10.45 | -- |
| Incyte Corp | 15.23bn | 121.38m | 51.15bn | 2.52k | 507.68 | 4.32 | 113.35 | 3.36 | 0.14 | 0.14 | 18.79 | 16.45 | 0.715 | 4.23 | 5.76 | 1,614,842.00 | 0.5698 | 9.07 | 0.7404 | 11.02 | 93.37 | 94.97 | 0.7969 | 13.68 | 1.82 | -- | 0.01 | 0.00 | 8.87 | 14.45 | 75.42 | 40.41 | -15.06 | -- |
| Cipla Ltd | 11.74bn | 1.98bn | 52.64bn | 27.76k | 26.57 | 4.19 | 21.51 | 4.48 | 55.39 | 55.39 | 328.19 | 351.20 | 0.803 | 1.58 | 5.08 | 9,549,060.00 | 13.58 | 10.09 | 16.44 | 12.40 | 67.01 | 58.63 | 16.92 | 12.66 | 2.82 | 69.41 | 0.016 | 21.39 | 13.28 | 9.51 | 47.10 | 21.96 | 20.68 | 34.08 |
| Royalty Pharma plc | 8.47bn | 4.28bn | 57.73bn | 89.00 | 10.25 | 2.26 | 21.53 | 6.82 | 2.56 | 2.56 | 3.80 | 11.63 | 0.1337 | -- | 72.15 | 25,460,710.00 | 10.11 | 9.57 | 13.30 | 12.42 | -- | -- | 75.64 | 67.80 | -- | -- | 0.4258 | 23.47 | 5.24 | 5.58 | 2,549.50 | -3.80 | 50.99 | -- |
| Viatris Inc | 56.23bn | -3.30bn | 58.56bn | 38.00k | -- | 0.7918 | 8.21 | 1.04 | -0.7389 | -0.7389 | 12.54 | 16.58 | 0.3219 | 2.23 | 4.94 | 396,013.20 | -1.89 | 0.0887 | -2.23 | 0.1061 | 42.49 | 40.29 | -5.87 | 0.2891 | 0.9615 | 2.37 | 0.443 | 560.11 | -5.14 | 6.17 | -97.37 | -30.53 | -16.88 | -- |
| Astellas Pharma Inc | 42.60bn | 1.32bn | 68.41bn | 14.75k | 51.70 | 1.84 | 11.35 | 1.61 | 30.42 | 30.42 | 986.34 | 854.61 | 0.5060 | 1.36 | 3.39 | 120,113,500.00 | 1.56 | 4.59 | 2.31 | 6.61 | 81.78 | 80.53 | 3.09 | 7.98 | 0.8623 | 15.32 | 0.3774 | 86.61 | 5.60 | 4.19 | -82.73 | -40.17 | 9.62 | 13.00 |
| Divi's Laboratories Ltd | 3.82bn | 813.20m | 69.38bn | 17.50k | 85.34 | 11.42 | 70.50 | 18.19 | 69.14 | 69.14 | 324.44 | 516.71 | 0.5768 | 1.13 | 4.27 | 4,922,286.00 | 12.29 | 16.55 | 13.32 | 18.22 | 59.91 | 56.24 | 21.31 | 26.38 | 4.80 | -- | 0.0006 | 34.32 | 0.9976 | 9.66 | -12.25 | 3.41 | 6.47 | 13.40 |
| Teva Pharmaceutical Industries Ltd | 62.59bn | -3.71bn | 71.47bn | 35.00k | -- | 3.16 | -- | 1.14 | -3.26 | -3.26 | 55.53 | 19.97 | 0.4001 | 2.05 | 4.90 | 1,788,132.00 | -2.99 | -3.14 | -4.34 | -4.29 | 51.01 | 48.14 | -7.46 | -9.87 | 0.6056 | 4.72 | 0.7483 | -- | 6.17 | -3.42 | 77.15 | -- | -4.17 | -- |
| Sandoz Group AG | -422.61bn | -422.61bn | 74.28bn | 23.85k | -- | 2.32 | -- | -- | -- | -- | -- | 17.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.7401 | -- | 0.3469 | -- | 7.23 | -- | -90.92 | -- | -- | -- |
| Bayer AG | 184.15bn | -3.47bn | 75.65bn | 100.87k | -- | 0.6283 | 2.65 | 0.4108 | -0.8957 | -0.8957 | 47.58 | 31.11 | 0.417 | 1.49 | 4.49 | 468,688.30 | -0.7815 | -1.79 | -1.06 | -2.38 | 57.14 | 59.02 | -1.87 | -4.80 | 0.8059 | 2.97 | 0.5728 | -- | -6.11 | 5.33 | -170.87 | -- | 1.19 | -47.66 |
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 5.63bn | 1.59bn | 76.88bn | 2.79k | 48.41 | 10.63 | -- | 13.67 | 5.10 | 5.10 | 18.08 | 23.24 | 0.6401 | 1.67 | 14.66 | 3,911,417.00 | 18.22 | 18.82 | 22.51 | 23.91 | 43.91 | 46.55 | 28.46 | 27.98 | 3.64 | -- | 0.0747 | 36.49 | 15.69 | 16.11 | 13.15 | 19.60 | 13.83 | 31.06 |
| Biogen Inc | 35.90bn | 6.04bn | 84.94bn | 7.57k | 14.10 | 1.38 | 10.04 | 2.37 | 11.07 | 11.07 | 65.83 | 112.90 | 0.34 | 0.8604 | 4.58 | 1,269,155.00 | 5.71 | 12.53 | 7.01 | 14.83 | 75.59 | 83.04 | 16.80 | 26.93 | 0.8039 | 4.89 | 0.2778 | 0.00 | -3.32 | -6.07 | -61.89 | -23.58 | -18.87 | -- |
Data as of Nov 21 2024. Currency figures normalised to Teva- Pharmaceutical Industries Ltd.'s reporting currency: Israeli Shekel ILS
9.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 36.31m | 3.21% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 34.90m | 3.08% |
| KSM Mutual Funds Ltd.as of 31 Jul 2024 | 9.36m | 0.83% |
| Meitav Mutual Funds Ltd.as of 31 Jul 2024 | 8.73m | 0.77% |
| Migdal Mutual Funds Ltd.as of 31 Jul 2024 | 4.13m | 0.37% |
| Harel Mutual Funds Ltd.as of 31 Jul 2024 | 3.40m | 0.30% |
| Charles Schwab Investment Management, Inc.as of 07 Nov 2024 | 2.52m | 0.22% |
| Canada Pension Plan Investment Boardas of 31 Mar 2024 | 2.48m | 0.22% |
| Psagot Mutual Funds Ltd.as of 31 Jul 2024 | 1.59m | 0.14% |
| Vanguard Global Advisers LLCas of 30 Sep 2024 | 1.16m | 0.10% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
